for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ajanta Pharma Ltd

AJPH.NS

Latest Trade

1,180.25INR

Change

-2.60(-0.22%)

Volume

44,141

Today's Range

1,167.00

 - 

1,195.00

52 Week Range

825.00

 - 

1,211.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

India's Ajanta Pharma Sept-Quarter Profit Falls

Nov 5 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::SEPT-QUARTER NET PROFIT 1.16 BILLION RUPEES VERSUS 1.25 BILLION RUPEES YEAR AGO.SEPT-QUARTER REVENUE FROM OPERATIONS 6.43 BILLION RUPEES VERSUS 5.44 BILLION RUPEES YEAR AGO.

India's Ajanta Pharma June-Qtr Consol PAT Rises

July 31 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::JUNE QUARTER CONSOL PAT 1.15 BILLION RUPEES VERSUS 1.06 BILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 6.12 BILLION RUPEES VERSUS 5.11 BILLION RUPEES YEAR AGO.

India's Ajanta Pharma March-Qtr Consol Profit Falls

April 30 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::MARCH QUARTER CONSOL PROFIT 888.9 MILLION RUPEES VERSUS PROFIT 944.9 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 5.15 BILLION RUPEES VERSUS 5.30 BILLION RUPEES YEAR AGO.

India's Ajanta Pharma Dec-Qtr Consol Profit More Than Halves

Jan 30 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::DEC QUARTER CONSOL NET PROFIT 669 MILLION RUPEES VERSUS PROFIT 1.47 BILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 4.85 BILLION RUPEES VERSUS 5.87 BILLION RUPEES YEAR AGO.

India's Ajanta Pharma Sept-Qtr Profit Falls

Oct 31 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::SEPT QUARTER CONSOL PROFIT 1.25 BILLION RUPEES VERSUS 1.32 BILLION RUPEES YEAR AGO.SEPT QTR CONSOL REVENUE FROM OPS 5.44 BLN RUPEES VS 5.40 BLN RUPEES YR AGO.

Ajanta Pharma Says NCLT Did Not Approve Proposed Scheme Of Co With Gabs Investments

Sept 10 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::AJANTA PHARMA -NCLT DID NOT DEEM IT FIT TO APPROVE PROPOSED SCHEME OF CO WITH GABS INVESTMENTS.

India's Ajanta Pharma June Quarter Consol PAT Rises

July 31 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::JUNE QUARTER CONSOL PAT 1.06 BILLION RUPEES VERSUS PAT OF 947.9 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 5.11 BILLION RUPEES VERSUS 4.73 BILLION RUPEES YEAR AGO.

Ajanta Pharma's Formulation Facility At Dahej Inspected By U.S. FDA

July 27 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::SAYS FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA FROM 23 JULY, 2018 TO 27 JULY, 2018.

Ajanta Pharma Says There Is No Action Against Co From Office Of Drug Controller General Of India

July 17 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::SAYS CLARIFIES ON NEWS ITEM,"DRUG CONTROTTER'S ACTION ON AJANTA PHARMA".SAYS THERE IS NO ACTION AGAINST CO FROM OFFICE OF DRUG CONTROLLER GENERAL OF INDIA."REFUTE ALLEGATIONS" MADE AGAINST COMPANY IN THE NEWS ITEM.

Ajanta Pharma Gets Shareholders' Nod For Reappointment Of Yogesh M Agrawal As MD

July 6 (Reuters) - Ajanta Pharma Ltd <AJPH.NS>::GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF YOGESH M AGRAWAL AS MD.GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF RAJESH M AGRAWAL AS JOINT MD.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up